ArticleScientific reports2026
Psychometric properties of the schizotypal personality questionnaire-brief revised (SPQ-BR) in a German-speaking sample.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Schizotypy refers to personality traits linked to an increased risk for schizophrenia-spectrum disorders (SSD). The Schizotypal Personality Questionnaire-Brief Revised (SPQ-BR) is a widely used 32-item self-report measure, but its psychometric properties in German-speaking populations are unexplored. This study comprised 738 individuals, including 33 with SSD, and 148 with other mental disorders. Participants (mean age: 38 years, 77% female) completed an online survey that included the German version of the SPQ-BR (SPQ-BR-G) and additional measures to assess convergent and discriminant validity. Reliability, latent factor structure, and validity were assessed. The SPQ-BR-G demonstrated excellent internal consistency (α = 0.91), good convergent validity (r = 0.52-0.58), and discriminant validity (r < 0.50) for the cognitive-perceptual and disorganized factors. Confirmatory factor analysis supported three- and four-factor solutions, while a single-factor model demonstrated poor fit. Subjective well-being was negatively associated with the SPQ-BR-G, after adjusting for sex, age, and education. Compared to the survey sample, SSD patients scored significantly higher on all factor levels and most items (p < 0.05), with 35% ranking in the top SPQ-BR-G decile. In SSD patients, moderate to high correlations were observed between the negative (r = 0.86, p < 0.001) and positive (r = 0.53, p < 0.05) dimensions of the Positive and Negative Syndrome Scale and the SPQ-BR-G. The SPQ-BR-G shows robust psychometric properties, supporting its use in schizotypy research. Its validation enhances cross-cultural comparisons and may aid in early risk and biological risk factor identification for SSD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.